NAV-242

N/A

Report date: 2025/06/09 11:16:54

Base Information

Drug NameNAV-242
Drug Alias NameNAV-242
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor ligand superfamily member 4Anti-Tumor necrosis factor α
TargetsTumor necrosis factor ligand superfamily member 4Tumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseColitis, UlcerativeHidradenitis Suppurativa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavigator Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavigator Medicines Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, UlcerativeHidradenitis Suppurativa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A